Shaanxi Kanghui Pharm Co Ltd (603139) - Total Assets
Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) holds total assets worth CN¥1.71 Billion CNY (≈ $249.51 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shaanxi Kanghui Pharm Co Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Shaanxi Kanghui Pharm Co Ltd stock valuation for the company's overall valuation and market capitalisation.
Shaanxi Kanghui Pharm Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Shaanxi Kanghui Pharm Co Ltd's total assets of CN¥1.71 Billion consist of 32.5% current assets and 67.5% non-current assets. Review total liabilities of Shaanxi Kanghui Pharm Co Ltd to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 5.9% |
| Accounts Receivable | CN¥226.74 Million | 12.5% |
| Inventory | CN¥163.14 Million | 9.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥86.29 Million | 4.8% |
| Goodwill | CN¥7.49 Million | 0.4% |
Asset Composition Trend (2012–2025)
This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 603139 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shaanxi Kanghui Pharm Co Ltd's current assets represent 32.5% of total assets in 2025, a decrease from 73.6% in 2012.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2025, down from 14.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 12.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 12.5% of total assets.
Shaanxi Kanghui Pharm Co Ltd Competitors by Total Assets
Key competitors of Shaanxi Kanghui Pharm Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Piramal Pharma Limited
NSE:PPLPHARMA
|
India | Rs179.65 Billion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
Shaanxi Kanghui Pharm Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.63 | 0.95 | 5.59 |
| Quick Ratio | 0.41 | 0.67 | 4.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-329.06 Million | CN¥-32.98 Million | CN¥666.05 Million |
Shaanxi Kanghui Pharm Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shaanxi Kanghui Pharm Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.46 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | -3.9% |
| Total Assets | CN¥1.81 Billion |
| Market Capitalization | $554.37 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shaanxi Kanghui Pharm Co Ltd's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shaanxi Kanghui Pharm Co Ltd's assets decreased by 3.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shaanxi Kanghui Pharm Co Ltd (2012–2025)
The table below shows the annual total assets of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.81 Billion ≈ $265.51 Million |
-3.89% |
| 2024-12-31 | CN¥1.89 Billion ≈ $276.25 Million |
-7.99% |
| 2023-12-31 | CN¥2.05 Billion ≈ $300.23 Million |
+12.63% |
| 2022-12-31 | CN¥1.82 Billion ≈ $266.57 Million |
-2.07% |
| 2021-12-31 | CN¥1.86 Billion ≈ $272.21 Million |
+41.87% |
| 2020-12-31 | CN¥1.31 Billion ≈ $191.87 Million |
+15.97% |
| 2019-12-31 | CN¥1.13 Billion ≈ $165.45 Million |
+1.85% |
| 2018-12-31 | CN¥1.11 Billion ≈ $162.46 Million |
+7.60% |
| 2017-12-31 | CN¥1.03 Billion ≈ $150.99 Million |
+57.54% |
| 2016-12-31 | CN¥654.97 Million ≈ $95.84 Million |
+13.24% |
| 2015-12-31 | CN¥578.40 Million ≈ $84.64 Million |
+13.94% |
| 2014-12-31 | CN¥507.65 Million ≈ $74.28 Million |
+12.81% |
| 2013-12-31 | CN¥450.00 Million ≈ $65.85 Million |
+42.52% |
| 2012-12-31 | CN¥315.74 Million ≈ $46.20 Million |
-- |
About Shaanxi Kanghui Pharm Co Ltd
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biolo… Read more